Defective RNA ribose synthesis in fibroblasts from patients with thiamine-responsive megaloblastic anemia (TRMA)

Blood

Volumn 102, Issue 10, 2003, Pages 3556-3561

  Boros, László G ^a   Steinkamp, Mara P ^b   Fleming, Judith C ^b   Lee, Wai Nang Paul ^b   Cascante, Marta ^b   Neufeld, Ellis J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; RIBOSE; RNA; THIAMINE;

APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL CYCLE; CITRIC ACID CYCLE; CONTROLLED STUDY; CULTURE MEDIUM; DIABETES MELLITUS; FIBROBLAST; GLYCOLYSIS; HEARING IMPAIRMENT; HUMAN; HUMAN CELL; MEGALOBLASTIC ANEMIA; NUCLEIC ACID SYNTHESIS; PENTOSE PHOSPHATE CYCLE; PRIORITY JOURNAL; RNA SYNTHESIS; THIAMINE RESPONSIVE MEGALOBLASTIC ANEMIA;

EID: 0242411640     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-05-1537     Document Type: Article

References (27)

1. Horecker BL, Hiatt HH. Pathways of carbohydrate metabolism in normal and neoplastic cells. N Engl J Med. 1958;258:177-184.
2. Horecker B-L. Pathways of carbohydrate metabolism and their physiological significance. J Chem Educ. 1965;42:244-253.
3. 2]glucose. Am J Physiol. 1998;274:E843-E851.
4. Fleming JC, Tartaglini E, Steinkamp MP, Schorderet DF, Cohen N, Neufeld EJ. The gene mutated in thiamine-responsive anaemia with diabetes and deafness (TRMA) encodes a functional thiamine transporter. Nat Genetics. 1999;22:305-308.
5. Stagg AR, Fleming JC, Baker MA, Sakamoto M, Cohen N, Neufeld EJ. Defective high-affinity thiamine transporter leads to cell death in thiamine-responsive megaloblastic anemia syndrome fibroblasts. J Clin Invest. 1999;103:723-729.
6. Matsushima K, MacManus JP, Hakim AM. Apoptosis is restricted to the thalamus in thiamine-deficient rats. Neuroreport. 1997;8:867-870.
7. Boros LG, Lee WN, Cascante M. Imatinib and chronic-phase leukemias. N Engl J Med. 2002;347:67-68.
8. Boren J, Cascante M, Marin S, et al. Gleevec (STI571) influences metabolic enzyme activities and glucose carbon flow toward nucleic acid and fatty acid synthesis in myeloid tumor cells. J Biol Chem. 2001;276:37747-37753.
9. Boros LG, Cascante M, Lee W-NP. Stable isotope-based dynamic metabolic profiling in disease and health. In: Harrigan GG, Goodacre R, eds. Metabolite Profiling: Its Role in Biomarker Discovery and Gene Function Analysis. Boston, MA: Kluwer Academic Publishers; 2003:141-164.
10. Boros LG, Cascante M, Lee WN. Metabolic profiling of cell growth and death in cancer: applications in drug discovery. Drug Discov Today. 2002;7:364-372.
11. Cascante M, Boros LG, Comin-Anduix B, de Atauri P, Centelles JJ, Lee WN. Metabolic control analysis in drug discovery and disease. Nat Biotechnol. 2002;20:243-249.
12. Neufeld EJ, Mandel H, Raz T, et al. Localization of the gene for thiamine-responsive megaloblastic anemia syndrome, on the long arm of chromosome 1, by homozygosity mapping. Am J Hum Genetics. 1997;61:1335-1341.
13. Gritli S, Omar S, Tartaglini E, et al. A novel mutation in the SLC19A2 gene in a Tunisian family with thiamine-responsive megaloblastic anemia, diabetes and deafness syndrome. Brit J Hematol. 2001;113:1-7.
14. Lee WN, Bergner EA, Guo ZK. Mass isotopomer pattern and precursor-product relationship. Biol Mass Spectrom. 1992;21:114-122.
15. Lee WN, Edmond J, Bassilian S, Morrow JW. Mass isotopomer study of glutamine oxidation and synthesis in primary culture of astrocytes. Dev Neurosci. 1996;18:469-477.
16. Leimer K-R, Rice RH, Gehrke CW. Complete mass spectra of N-TAB esters of amino acids. J Chromatogr. 1977;141:121-144.
17. Lee WN, Lim S, Bassilian S, Bergner EA, Edmond J. Fatty acid cycling in human hepatoma cells and the effects of troglitazone. J Biol Chem. 1998;273:20929-20934.
18. Lee WN, Byerley LO, Bassilian S, et al. Isotopomer study of lipogenesis in human hepatoma cells in culture: contribution of carbon and hydrogen atoms from glucose. Analytical Biochem. 1995;226:100-112.
19. Sabate L, Franco R, Canela EI, Centelles JJ, Cascante M. A model of the pentose phosphate pathway in rat liver cells. Mol Cell Biochem. 1995;142:9-17.
20. Comin-Anduix B, Boren J, Martinez S, et al. The effect of thiamine supplementation on tumor proliferation: a metabolic control analysis study. Europ J Biochem. 2001;268:4177-4182.
21. Boros LG, Bassilian S, Lim S, Lee WN. Genistein inhibits nonoxidative ribose synthesis in MIA pancreatic adenocarcinoma cells: a new mechanism of controlling tumor growth. Pancreas. 2001;22:1-7.
22. Rogers LE, Porter SF, Sindbury JB. Thiamine-responsive megaloblastic anemia. J Pediatr. 1969;74:494-504.
23. Haworth C, Evans DI, Mitra J, Wickramasinghe SN. Thiamine responsive anaemia: a study of two further cases. Br J Haematol. 1982;50:549-561.
24. Dutta B, Huang W, Molero M, et al. Cloning of the human thiamine transporter, a member of the folate transporter family. J Biol Chem. 1999;274:31925-31929.
25. Zhao R, Gao F, Wang Y, Diaz GA, Gelb BD, Goldman ID. Impact of the reduced folate carrier on the accumulation of active thiamin metabolites in murine leukemia cells. J Biol Chem. 2001;276:1114-1118.
26. Boros LG, Puigjaner J, Cascante M, Lee WN, Brandes JL, Bassilian S. Oxythiamine and dehydroepiandrosterone inhibit the non-oxidative synthesis of ribose and tumor cell proliferation. Cancer Res. 1997;57:4242-4248.
27. Banki K, Hutter E, Colombo E, Gonchoroff NJ, Perl A. Glutathione levels and sensitivity to apoptosis are regulated by changes in transaldolase expression. J Biol Chem. 1996;271:32994-33001.